(EYPT) Eyepoint Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Eyepoint Pharmaceuticals | (EYPT) share price targets
Complete technical analysis of Eyepoint Pharmaceuticals (EYPT) by charts plus indicators, forecast predictions and share price targets for Eyepoint Pharmaceuticals (EYPT)
Eyepoint Pharmaceuticals trades in USA in Capital Goods sector.
Showing technical analysis as on 2024-11-11 View latest technical analysis
10 day averaged volume of Eyepoint Pharmaceuticals is 1625690
| Date | Daily Closing Price | Open | High | Low | Volume |
| 11 Mon Nov 2024 | 12.00 | 11.73 | 12.23 | 11.64 | 0.337 times |
| 08 Fri Nov 2024 | 11.63 | 11.59 | 11.77 | 11.26 | 0.33 times |
| 07 Thu Nov 2024 | 11.59 | 12.41 | 12.50 | 11.35 | 0.441 times |
| 06 Wed Nov 2024 | 12.08 | 11.99 | 12.37 | 11.76 | 0.466 times |
| 05 Tue Nov 2024 | 11.61 | 11.53 | 11.71 | 11.06 | 0.257 times |
| 04 Mon Nov 2024 | 11.70 | 12.06 | 12.10 | 11.30 | 0.494 times |
| 01 Fri Nov 2024 | 12.06 | 11.88 | 12.47 | 11.31 | 0.516 times |
| 31 Thu Oct 2024 | 11.76 | 11.28 | 12.09 | 10.96 | 0.884 times |
| 30 Wed Oct 2024 | 11.46 | 11.41 | 12.36 | 10.90 | 2.765 times |
| 29 Tue Oct 2024 | 11.54 | 12.02 | 12.75 | 11.14 | 1.038 times |
Share price targets for Eyepoint Pharmaceuticals (EYPT)
| Target Type | Value |
| Downside Target | 7.40 |
| Downside Target | 7.61 |
| Downside Target | 8.82 |
| Downside Target | 9.23 |
| Downside Target | 9.72 |
| Downside Target | 10.00 |
| Downside Target | 10.35 |
| Downside Target | 11.06 |
| Downside Target | 11.64 |
| Upside Target | 12.23 |
| Upside Target | 12.50 |
| Upside Target | 13.99 |
Intraday share price targets for Eyepoint Pharmaceuticals (EYPT)
| Target Type | Value |
| Downside Intraday Target | 11.68 |
| Downside Intraday Target | 11.37 |
| Upside Intraday Target | 12.27 |
| Upside Intraday Target | 12.55 |
| Downside Intraday Target | 11.96 |
Weekly technical analysis of Eyepoint Pharmaceuticals (EYPT)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 11 Mon Nov 2024 | 12.00 | 11.73 | 12.23 | 11.64 | 0.17 times |
| 08 Fri Nov 2024 | 11.63 | 12.06 | 12.50 | 11.06 | 0.248 times |
| 01 Fri Nov 2024 | 12.06 | 10.68 | 13.99 | 10.35 | 6.69 times |
| 25 Fri Oct 2024 | 9.50 | 11.03 | 11.20 | 9.23 | 0.486 times |
| 18 Fri Oct 2024 | 11.05 | 8.92 | 11.46 | 8.82 | 1.625 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Eyepoint Pharmaceuticals (EYPT)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 11 Mon Nov 2024 | 12.00 | 11.88 | 12.50 | 11.06 | 0.21 times |
| 31 Thu Oct 2024 | 11.76 | 7.94 | 13.99 | 7.78 | 1.781 times |
| 30 Mon Sep 2024 | 7.99 | 8.82 | 9.72 | 7.61 | 0.916 times |
| 30 Fri Aug 2024 | 8.95 | 9.86 | 10.00 | 7.40 | 0.77 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Eyepoint Pharmaceuticals (EYPT)
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Eyepoint Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Eyepoint Pharmaceuticals in short term and the buy signal is strong.
Eyepoint Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Eyepoint Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Eyepoint Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 11.65 and Eyepoint Pharmaceuticals (EYPT) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Eyepoint Pharmaceuticals (EYPT) stock. Volume based technical analysis of Eyepoint Pharmaceuticals (EYPT) stock is negative.
Eyepoint Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Eyepoint Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Eyepoint Pharmaceuticals in short term and the buy signal is strong.
Eyepoint Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Eyepoint Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Eyepoint Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 11.65 and Eyepoint Pharmaceuticals (EYPT) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Eyepoint Pharmaceuticals (EYPT) stock. Volume based technical analysis of Eyepoint Pharmaceuticals (EYPT) stock is negative.
Eyepoint Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.